α-glucosidase inhibitors: New therapeutic agents for chronic heart failure

Hypertension Research

Volumn 29, Issue 10, 2006, Pages 741-742

  Node, Koichi ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

glucosidase inhibitor; Diabetes mellitus; Heart failure; Impaired glucose tolerance

Indexed keywords

ACARBOSE; ALPHA GLUCOSIDASE INHIBITOR; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FATTY ACID; GLUCOSE; INSULIN; RENIN INHIBITOR; VOGLIBOSE;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL METABOLISM; CONGESTIVE CARDIOMYOPATHY; DISEASE ASSOCIATION; DISEASE SEVERITY; EDITORIAL; ENDOTHELIAL DYSFUNCTION; FATTY ACID SYNTHESIS; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HEART FAILURE; HEART MUSCLE; HEART PERFORMANCE; HUMAN; HYPERGLYCEMIA; HYPERMETABOLISM; HYPERTENSION; IMMOBILIZATION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MORTALITY; MUSCLE PERFUSION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; POSTPRANDIAL STATE; PREVALENCE; RISK REDUCTION; TREATMENT OUTCOME;

ACARBOSE; ALPHA-GLUCOSIDASES; CHRONIC DISEASE; ENZYME INHIBITORS; HEART FAILURE, CONGESTIVE; HUMANS;

EID: 33751573419     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.29.741     Document Type: Editorial

References (11)

1. American Heart Association: 1999 Heart and Stroke Statistical Update. Dallas, American Heart Association, 1998.
2. Rich MW: Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults. J Am Geriatr Soc 1997; 45: 974-968.
3. King H, Aubert RE, Herman VVH: Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-1431.
4. Kannel WB, McGee DL: Diabetes and cardiovascular disease. The Framingham study. JAMA 1979; 241: 2035-2038.
5. Iribarren C, Karter AJ, Go AS, et al: Glycemic control and heart failure among adult patients with diabetes. Circulation 2001; 103: 2668-2673.
6. Rodrigues B, McNeill JH: The diabetic heart: metabolic causes for the development of a cardiomyopathy. Cardiovasc Res 1992; 26: 913-922.
7. Rodrigues B, Cam MC, McNeill JH: Metabolic disturbances in diabetic cardiomyopathy. Mol Cell Biochem 1998; 180: 53-57.
8. Lopaschuk GD: Abnormal mechanical function in diabetes: relationship to altered myocardial carbohydrate/lipid metabolism. Coron Artery Dis 1996; 7: 116-123.
9. Liao Y, Takashima S, Zhao H, et al: Control of plasma glucose with alpha-glucosidase inhibitor attenuates oxidative stress and slows the progression of heart failure in mice. Cardiovasc Res 2006; 70: 107-116.
10. Kim J, Nakatani S, Hashimura K, et al: Abonormal glucose tolerance contributes to the progression of chronic heart failure in patients with dilated cardiomyopathy. Hypertens Res 2006; 29: 775-782.
11. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M, STOP-NIDDM Trial Research Group: Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NlDDM trial. JAMA 2003; 290: 486-494.